- Home
- ASND vs FRPT Comparison
ASND vs FRPT Comparison
Compare ASND & FRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- FRPT
- Stock Information
- Founded
- ASND 2006
- FRPT 2004
- Country
- ASND Denmark
- FRPT United States
- Employees
- ASND N/A
- FRPT N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- FRPT Packaged Foods
- Sector
- ASND Health Care
- FRPT Consumer Staples
- Exchange
- ASND Nasdaq
- FRPT Nasdaq
- Market Cap
- ASND 7.7B
- FRPT 6.5B
- IPO Year
- ASND 2015
- FRPT 2014
- Fundamental
- Price
- ASND $152.43
- FRPT $100.28
- Analyst Decision
- ASND Strong Buy
- FRPT Strong Buy
- Analyst Count
- ASND 14
- FRPT 15
- Target Price
- ASND $197.36
- FRPT $164.27
- AVG Volume (30 Days)
- ASND 519.7K
- FRPT 1.2M
- Earning Date
- ASND 02-12-2025
- FRPT 02-20-2025
- Dividend Yield
- ASND N/A
- FRPT N/A
- EPS Growth
- ASND N/A
- FRPT N/A
- EPS
- ASND N/A
- FRPT 0.93
- Revenue
- ASND $376,478,932.00
- FRPT $975,177,000.00
- Revenue This Year
- ASND $47.51
- FRPT $29.92
- Revenue Next Year
- ASND $88.30
- FRPT $24.46
- P/E Ratio
- ASND N/A
- FRPT $107.83
- Revenue Growth
- ASND 36.34
- FRPT 27.16
- 52 Week Low
- ASND $111.09
- FRPT $90.07
- 52 Week High
- ASND $161.00
- FRPT $164.07
- Technical
- Relative Strength Index (RSI)
- ASND 66.26
- FRPT 13.87
- Support Level
- ASND $118.03
- FRPT $126.88
- Resistance Level
- ASND $157.37
- FRPT $132.86
- Average True Range (ATR)
- ASND 6.50
- FRPT 8.38
- MACD
- ASND 3.62
- FRPT -4.59
- Stochastic Oscillator
- ASND 87.44
- FRPT 4.31
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.
About FRPT Freshpet Inc.
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. The former two store types accounted for 89% of 2023 sales, with grocery stores representing the primary driver of footprint growth. Freshpet primarily targets dogs (92% of sales), with cats and treats comprising the rest of its sales. Geographically, the company's home US market, where all its food is produced, accounts for about 96% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.